Daniella Babu

Daniella Babu, PhD, is an accomplished professional in the medical strategy and pharmaceutical domains, currently serving as Director of Medical Strategy and Vice President at AREA 23 on Hudson since January 2025. Prior to this role, Daniella held the position of VP and Medical Director at Complete HealthVizion from April 2021 to December 2024, and served in various capacities at Envision Pharma Group from February 2014 to March 2021, including Scientific Director and Senior Medical Writer. Academic achievements include a PhD in Pharmacology from the University of Virginia and experience as a postdoctoral fellow at the University of Pennsylvania, where research focused on the mechanisms of GLP1 receptor in adipose development. Early career experiences include roles at Genaissance Pharmaceuticals and internships at Yale University and the University of Pennsylvania's Office of Cooperative Research and Center for Technology Transfer.